138 related articles for article (PubMed ID: 21098690)
21. [Effect of recombinant human soluble thrombomodulin in patients with solid carcinoma with DIC].
Asano Y; Kashiwagi S; Shibutani M; Yamazoe S; Noda S; Sakurai K; Nagahara H; Kimura K; Kawajiri H; Toyokawa T; Amano R; Kubo N; Tanaka H; Muguruma K; Ohtani H; Takashima T; Yashiro M; Onoda N; Maeda K; Ohira M; Hirakawa K
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2503-5. PubMed ID: 25731571
[TBL] [Abstract][Full Text] [Related]
22. TAFRO Syndrome with Disseminated Intravascular Coagulation Successfully Treated with Tocilizumab and Recombinant Thrombomodulin.
Takayama Y; Kubota T; Ogino Y; Ohnishi H; Togitani K; Yokoyama A
Intern Med; 2018 May; 57(9):1291-1296. PubMed ID: 29279488
[TBL] [Abstract][Full Text] [Related]
23. A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation.
Vincent JL; Ramesh MK; Ernest D; LaRosa SP; Pachl J; Aikawa N; Hoste E; Levy H; Hirman J; Levi M; Daga M; Kutsogiannis DJ; Crowther M; Bernard GR; Devriendt J; Puigserver JV; Blanzaco DU; Esmon CT; Parrillo JE; Guzzi L; Henderson SJ; Pothirat C; Mehta P; Fareed J; Talwar D; Tsuruta K; Gorelick KJ; Osawa Y; Kaul I
Crit Care Med; 2013 Sep; 41(9):2069-79. PubMed ID: 23979365
[TBL] [Abstract][Full Text] [Related]
24. Thrombomodulin alfa prevents the decrease in platelet aggregation in rat models of disseminated intravascular coagulation.
Kimpara N; Tawara S; Kawasaki K
Thromb Res; 2019 Jul; 179():73-80. PubMed ID: 31096113
[TBL] [Abstract][Full Text] [Related]
25. Treatment responses for disseminated intravascular coagulation in 25 children treated with recombinant thrombomodulin: a single institution experience.
Yagasaki H; Kato M; Shimozawa K; Hirai M; Nishikawa E; Okuma H; Ishii W; Imai Y; Matsumura M; Yonezawa R; Yoshikawa K; Shichino H; Chin M; Mugishima H
Thromb Res; 2012 Dec; 130(6):e289-93. PubMed ID: 23123162
[TBL] [Abstract][Full Text] [Related]
26. Impact of Recombinant Human Soluble Thrombomodulin for Disseminated Intravascular Coagulation.
Itoh S; Shirabe K; Kohnoe S; Sadanaga N; Kajiyama K; Yamagata M; Anai H; Harimoto N; Ikegami T; Yoshizumi T; Maehara Y
Anticancer Res; 2016 May; 36(5):2493-6. PubMed ID: 27127163
[TBL] [Abstract][Full Text] [Related]
27. [Successful treatment using recombinant thrombomodulin for disseminated intravascular coagulation associated with recurrent prosthetic valve endocarditis].
Masuda S; Adachi O; Ito K; Matsuo S; Hayatsu Y; Suzuki Y; Saito T; Akiyama M; Kumagai K; Motoyoshi N; Kawamoto S; Saiki Y
Kyobu Geka; 2013 Feb; 66(2):101-5. PubMed ID: 23381354
[TBL] [Abstract][Full Text] [Related]
28. Decreased thrombomodulin mRNA expression on peripheral monocytes in disseminated intravascular coagulation patients relates to poor outcomes: the ex vivo effects of lipopolysaccharide and thrombin on monocyte thrombomodulin and CD14 mRNA.
Hong SK; Kim JE; Han KS; Kim HK
Thromb Res; 2013 Sep; 132(3):392-7. PubMed ID: 23954259
[TBL] [Abstract][Full Text] [Related]
29. [The effect of the recombinant thrombomodulin which merged to hematological malignancy].
Kawasugi K
Rinsho Byori; 2011 Feb; Suppl 147():181-7. PubMed ID: 21761769
[No Abstract] [Full Text] [Related]
30. Clinical Outcomes of Recombinant Human-soluble Thrombomodulin Treatment for Disseminated Intravascular Coagulation in Solid Tumors.
Kashiwagi S; Asano Y; Takahashi K; Shibutani M; Amano R; Tomita S; Hirakawa K; Ohira M
Anticancer Res; 2019 May; 39(5):2259-2264. PubMed ID: 31092417
[TBL] [Abstract][Full Text] [Related]
31. Clinical features and outcomes of 35 disseminated intravascular coagulation cases treated with recombinant human soluble thrombomodulin at a single institution.
Kawano N; Yoshida S; Ono N; Himeji D; Nagahiro Y; Sayaka Kawano ; Yamashita K; Ikeda N; Uezono S; Ochiai H; Kawano F; Kikuchi I; Ishikawa F; Shimoda K; Ueda A; Akashi K
J Clin Exp Hematop; 2011; 51(2):101-7. PubMed ID: 22104308
[TBL] [Abstract][Full Text] [Related]
32. Addition of recommendations for the use of recombinant human thrombomodulin to the "Expert consensus for the treatment of disseminated intravascular coagulation in Japan".
Wada H; ; Okamoto K; Iba T; Kushimoto S; Kawasugi K; Gando S; Madoiwa S; Uchiyama T; Mayumi T; Seki Y
Thromb Res; 2014 Oct; 134(4):924-5. PubMed ID: 25135793
[No Abstract] [Full Text] [Related]
33. [The efficacy of early use of recombinant soluble thrombomodulin for disseminated intravascular coagulation complicated with hematologic malignancies].
Usami M; Kuroda H; Yoshida M; Sakamoto H; Shimoyama S; Kanari Y; Yamada M; Abe T; Fujii S; Maeda M
Rinsho Ketsueki; 2015 Jun; 56(6):673-80. PubMed ID: 26256878
[TBL] [Abstract][Full Text] [Related]
34. [Successful treatment with recombinant thrombomodulin for disseminated intravascular coagulation complicated with hemophagocytic syndrome].
Yamazaki H; Kondo T; Tatsumi G; Kotani S; Arai Y; Shirakawa K; Kitano T; Hishizawa M; Kadowaki N; Takaori-Kondo A
Rinsho Ketsueki; 2015 Mar; 56(3):312-6. PubMed ID: 25876785
[TBL] [Abstract][Full Text] [Related]
35. Blood levels of endothelin-1 and thrombomodulin in patients with disseminated intravascular coagulation and sepsis.
Endo S; Inada K; Nakae H; Takakuwa T; Kasai T; Yamada Y; Suzuki T; Taniguchi S; Yoshida M
Res Commun Mol Pathol Pharmacol; 1995 Nov; 90(2):277-88. PubMed ID: 8747795
[TBL] [Abstract][Full Text] [Related]
36. Successful treatment of disseminated intravascular coagulation in a child with acute myelogenous leukaemia using recombinant thrombomodulin.
Ogawa E; Yagasaki H; Kato M; Shichino H; Chin M; Mugishima H
Br J Haematol; 2010 Jun; 149(6):911-2. PubMed ID: 20346017
[No Abstract] [Full Text] [Related]
37. Use of recombinant human soluble thrombomodulin in the management of HELLP syndrome complicated by DIC.
Ikezoe T; Ikenoue N; Uchikawa N; Kojima S; Fukaya T; Yokoyama A
Thromb Res; 2010 Sep; 126(3):e238-40. PubMed ID: 20627281
[No Abstract] [Full Text] [Related]
38. Recombinant thrombomodulin and activated protein C in the treatment of disseminated intravascular coagulation.
Maruyama I
Thromb Haemost; 1999 Aug; 82(2):718-21. PubMed ID: 10605773
[No Abstract] [Full Text] [Related]
39. Postmarketing Surveillance of Recombinant Human Soluble Thrombomodulin (Thrombomodulin α) in Pediatric Patients With Disseminated Intravascular Coagulation.
Shirahata A; Mimuro J; Takahashi H; Tsuji H; Kitajima I; Matsushita T; Eguchi Y; Kitamura N; Honda G; Sakata Y
Clin Appl Thromb Hemost; 2014 Jul; 20(5):465-72. PubMed ID: 24563247
[TBL] [Abstract][Full Text] [Related]
40. Recombinant soluble human thrombomodulin (thrombomodulin alfa) in the treatment of neonatal disseminated intravascular coagulation.
Shirahata A; Mimuro J; Takahashi H; Kitajima I; Tsuji H; Eguchi Y; Matsushita T; Kajiki M; Honda G; Sakata Y
Eur J Pediatr; 2014 Mar; 173(3):303-11. PubMed ID: 24005342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
